Craig Huttenbach
Analyst, Morgan Stanley
Replay available
Hinge Health, Inc. Class A (NYSE: HNGE) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Analyst, Morgan Stanley
Analyst, Barclays
Analyst, Raymond James
CFO
Co-founder and CEO
Analyst, NeedHemCo
Analyst, KeyBank
Head of Investor Relations
Analyst, Piper Sandler
Analyst, RBC Capital Markets
Analyst, Evercore ISI
Analyst, Wells Fargo
Analyst, Canaccord Genuity
Analyst, Truist Securities
Analyst
Ladies and gentlemen, thank you for joining us and welcome to the Hinge Health first quarter 2026 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please raise your hand. If you have dialed in to today's call, please press star nine to raise your hand. and star six to unmute. I will now hand the conference over to Bianca Buck, Head of Investor Relations. Bianca, please go ahead. Good afternoon and welcome to Hinge Health's first quarter 2026 earnings call. I'm Bianca Buck, Head of Investor Relations. With me on the call are Daniel Perez, our co-founder and CEO, and James Budge, our CFO. Our president, Jim Pursley, is spending this week advancing relationships with some of the largest state and local governments in the country, so can't be with us today. I want to thank everyone for joining us. As a reminder, this conference call is being recorded. All relevant materials are available on the investor relations section of our website. Today's discussion will include forward-looking statements, which are subject to various risks, uncertainties, and assumptions. These statements reflect our current views and expectations regarding future events, including expected performance of our business, future financial results, and growth strategies. While these statements represent our good faith judgment and beliefs, actual results may differ materially from those projected or implied. We undertake no obligation to update any forward-looking statements except as required by law. For a detailed discussion of the risks, please refer to our SEC filings, including our annual report on Form 10-K for the year ended December 31st, 2025. We expect to file our latest quarterly report on Form 10-Q in the coming...